Global Blood Pressure Targets and Treatment Thresholds Across Major Guidelines (2025 Update)
Global Blood Pressure Targets and Treatment Thresholds Across Major Guidelines (2025 Update)
AHA/ACC 2025 (USA)
• Start treatment at ≥130/80 mm Hg
• Target:
• <130/80 mm Hg for most
• Encourage <120 SBP (if tolerated, especially high-risk)
• Reflects shift toward intensive BP control
ESC 2024 / ESH 2023 (Europe)
• Classification:
• 130–139 / 85–89 → “high-normal”
• Treatment:
• Pharmacotherapy mainly for high-risk patients
• Targets:
• Generally <130/80 mm Hg
• ❗ Avoid aggressive lowering:
• Do NOT target <120 SBP or <70 DBP
ISH 2020 (Global)
• Initial goal:
• Reduce BP by ≥20/10 mm Hg
• Targets:
• Most: <140/90 mm Hg
• <65 yrs: <130/80 (but >120/70)
• ≥65 yrs: <140/90, individualized
NICE 2024 (UK)
• Clinic targets:
• <80 yrs: <140/90 mm Hg
• ≥80 yrs: <150/90 mm Hg
• Home / ambulatory BP:
• Targets 5 mm Hg lower
• (<135/85 or <145/85)
WHO 2022
• Start treatment after confirmed HTN + lifestyle
• Target:
• <140/90 mm Hg
• Focus:
• Practical global implementation
• Control rates still <14% worldwide
KDIGO 2024 (CKD-specific)
• Target:
• SBP <120 mm Hg
• Based on:
• Intensive control benefits in CKD
• More aggressive than general guidelines
Acute Settings (Important)
• Hypertensive emergency:
• ↓ SBP ≤25% in first hour
• Then ~160/100 in 2–6 hours
• Gradual normalization over 24–48 hours
• Intracerebral hemorrhage:
• Target SBP <140 mm Hg
• Safe and reduces hematoma expansion
🎯 Key Clinical Insights
• Global convergence toward:
• <130/80 mm Hg in appropriate patients
• Differences:
• Europe → more conservative (avoid <120)
• USA & KDIGO”International kidney guidelines→ more intensive
• ISH / WHO → pragmatic for global settings
🧠 Bottom Line
• One size does NOT fit all
• Individualize based on:
• Age
• Risk profile
• Tolerance
• CKD status
👉 Practical optimal range:
• Most patients: SBP 120–130 mm Hg
• Avoid:
• <120 (unless carefully selected)
• ≥130 (associated with higher risk)
(Jordan cardiac society national protocols):
• Adopt a pragmatic hybrid model:
• General Population -Hypertension Definition : <140/90 mm Hg
• High-risk (ASCVD, diabetes, CKD): <130/80 mm Hg
• Suitable for mixed-resource systems
• Focus on high-yield risk groups)
Reference:
KDIGO Clinical Practice Guideline (2024) — Blood Pressure in CKD (as summarized in AHA/ACC 2025 commentary)
Link:
